Novel biomarkers for diabetic kidney disease
Although diabetic kidney disease (DKD) remains one of the leading causes of reduced lifespan in patients with diabetes mellitus; its prevalence has failed to decline over the past 30 years. To identify those at high risk of developing DKD and disease progression at an early stage, extensive research...
Main Authors: | Chan-Young Jung, Tae-Hyun Yoo |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Nephrology
2022-09-01
|
Series: | Kidney Research and Clinical Practice |
Subjects: | |
Online Access: | http://www.krcp-ksn.org/upload/pdf/j-krcp-22-084.pdf |
Similar Items
-
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
by: Chan-Young Jung, et al.
Published: (2022-03-01) -
Biomarker Discovery in Animal Health and Disease: The Application of Post-Genomic Technologies
by: Rowan E. Moore, et al.
Published: (2007-01-01) -
Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
by: Mu X, et al.
Published: (2022-01-01) -
Anthocyanin improves kidney function in diabetic kidney disease by regulating amino acid metabolism
by: Yi-Xi Li, et al.
Published: (2022-11-01) -
Early renal structural changes and potential biomarkers in diabetic nephropathy
by: Hao Liu, et al.
Published: (2022-11-01)